Validity of [123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity

Liesbeth Reneman, Jan Booij, Jan B A Habraken, Kora De Bruin, George Hatzidimitriou, Gerard J. Den Heeten, George Ricaurte

Research output: Contribution to journalArticle

Abstract

Recent [123I]β-CIT single-photon emission computed tomography (SPECT) studies revealed decreased serotonin transporters (SERT) density in the brain of humans with a history of MDMA ("Ecstasy") use. However, [123I]β-CIT SPECT has until now not been validated as a method for detecting such serotonergic lesions. Therefore, the present study was undertaken. Following baseline [123I]β-CIT SPECT scans, a rhesus monkey was treated with MDMA (5 mg/kg, s.c. twice daily for 4 consecutive days). SPECT studies 4, 10, and 31 days after MDMA treatment revealed decreases in [123I]β-CIT binding ratios in the SERT-rich brain region studied (hypothalamic/midbrain region), with SERT density reduced by 39% in this brain region 31 days after treatment. Data obtained with SPECT studies correlated well with SERT density determined with autoradiography after sacrifice of the animal (-34%). In addition, ex vivo [123I]β-CIT binding studies in rats 1 week after treatment with neurotoxic doses of MDMA (20 mg/kg s.c. twice daily for 4 consecutive days) revealed significant reductions in [123I]β-CIT binding in SERT-rich regions (including the hypothalamus) when compared to saline-treated rats. The combined results of these studies indicate that SPECT imaging of SERT with [123I]β-CIT can detect changes in SERT density secondary to MDMA-induced neurotoxicity in the hypothalamic/midbrain region, and possibly other brain regions.

Original languageEnglish (US)
Pages (from-to)199-205
Number of pages7
JournalSynapse
Volume46
Issue number3
DOIs
StatePublished - Dec 1 2002

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Serotonin Plasma Membrane Transport Proteins
Single-Photon Emission-Computed Tomography
Brain
Mesencephalon
Macaca mulatta
Autoradiography
Hypothalamus

Keywords

  • 5-HT
  • [I]β-CIT SPECT
  • MDMA
  • Neurotoxicity
  • Validity

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology
  • Pharmacology
  • Advanced and Specialized Nursing

Cite this

Reneman, L., Booij, J., Habraken, J. B. A., De Bruin, K., Hatzidimitriou, G., Den Heeten, G. J., & Ricaurte, G. (2002). Validity of [123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. Synapse, 46(3), 199-205. https://doi.org/10.1002/syn.10130

Validity of [123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. / Reneman, Liesbeth; Booij, Jan; Habraken, Jan B A; De Bruin, Kora; Hatzidimitriou, George; Den Heeten, Gerard J.; Ricaurte, George.

In: Synapse, Vol. 46, No. 3, 01.12.2002, p. 199-205.

Research output: Contribution to journalArticle

Reneman, L, Booij, J, Habraken, JBA, De Bruin, K, Hatzidimitriou, G, Den Heeten, GJ & Ricaurte, G 2002, 'Validity of [123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity', Synapse, vol. 46, no. 3, pp. 199-205. https://doi.org/10.1002/syn.10130
Reneman L, Booij J, Habraken JBA, De Bruin K, Hatzidimitriou G, Den Heeten GJ et al. Validity of [123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. Synapse. 2002 Dec 1;46(3):199-205. https://doi.org/10.1002/syn.10130
Reneman, Liesbeth ; Booij, Jan ; Habraken, Jan B A ; De Bruin, Kora ; Hatzidimitriou, George ; Den Heeten, Gerard J. ; Ricaurte, George. / Validity of [123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. In: Synapse. 2002 ; Vol. 46, No. 3. pp. 199-205.
@article{7247efb6935f4ec4a3a932f0edb7fd56,
title = "Validity of [123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity",
abstract = "Recent [123I]β-CIT single-photon emission computed tomography (SPECT) studies revealed decreased serotonin transporters (SERT) density in the brain of humans with a history of MDMA ({"}Ecstasy{"}) use. However, [123I]β-CIT SPECT has until now not been validated as a method for detecting such serotonergic lesions. Therefore, the present study was undertaken. Following baseline [123I]β-CIT SPECT scans, a rhesus monkey was treated with MDMA (5 mg/kg, s.c. twice daily for 4 consecutive days). SPECT studies 4, 10, and 31 days after MDMA treatment revealed decreases in [123I]β-CIT binding ratios in the SERT-rich brain region studied (hypothalamic/midbrain region), with SERT density reduced by 39{\%} in this brain region 31 days after treatment. Data obtained with SPECT studies correlated well with SERT density determined with autoradiography after sacrifice of the animal (-34{\%}). In addition, ex vivo [123I]β-CIT binding studies in rats 1 week after treatment with neurotoxic doses of MDMA (20 mg/kg s.c. twice daily for 4 consecutive days) revealed significant reductions in [123I]β-CIT binding in SERT-rich regions (including the hypothalamus) when compared to saline-treated rats. The combined results of these studies indicate that SPECT imaging of SERT with [123I]β-CIT can detect changes in SERT density secondary to MDMA-induced neurotoxicity in the hypothalamic/midbrain region, and possibly other brain regions.",
keywords = "5-HT, [I]β-CIT SPECT, MDMA, Neurotoxicity, Validity",
author = "Liesbeth Reneman and Jan Booij and Habraken, {Jan B A} and {De Bruin}, Kora and George Hatzidimitriou and {Den Heeten}, {Gerard J.} and George Ricaurte",
year = "2002",
month = "12",
day = "1",
doi = "10.1002/syn.10130",
language = "English (US)",
volume = "46",
pages = "199--205",
journal = "Synapse",
issn = "0887-4476",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Validity of [123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity

AU - Reneman, Liesbeth

AU - Booij, Jan

AU - Habraken, Jan B A

AU - De Bruin, Kora

AU - Hatzidimitriou, George

AU - Den Heeten, Gerard J.

AU - Ricaurte, George

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Recent [123I]β-CIT single-photon emission computed tomography (SPECT) studies revealed decreased serotonin transporters (SERT) density in the brain of humans with a history of MDMA ("Ecstasy") use. However, [123I]β-CIT SPECT has until now not been validated as a method for detecting such serotonergic lesions. Therefore, the present study was undertaken. Following baseline [123I]β-CIT SPECT scans, a rhesus monkey was treated with MDMA (5 mg/kg, s.c. twice daily for 4 consecutive days). SPECT studies 4, 10, and 31 days after MDMA treatment revealed decreases in [123I]β-CIT binding ratios in the SERT-rich brain region studied (hypothalamic/midbrain region), with SERT density reduced by 39% in this brain region 31 days after treatment. Data obtained with SPECT studies correlated well with SERT density determined with autoradiography after sacrifice of the animal (-34%). In addition, ex vivo [123I]β-CIT binding studies in rats 1 week after treatment with neurotoxic doses of MDMA (20 mg/kg s.c. twice daily for 4 consecutive days) revealed significant reductions in [123I]β-CIT binding in SERT-rich regions (including the hypothalamus) when compared to saline-treated rats. The combined results of these studies indicate that SPECT imaging of SERT with [123I]β-CIT can detect changes in SERT density secondary to MDMA-induced neurotoxicity in the hypothalamic/midbrain region, and possibly other brain regions.

AB - Recent [123I]β-CIT single-photon emission computed tomography (SPECT) studies revealed decreased serotonin transporters (SERT) density in the brain of humans with a history of MDMA ("Ecstasy") use. However, [123I]β-CIT SPECT has until now not been validated as a method for detecting such serotonergic lesions. Therefore, the present study was undertaken. Following baseline [123I]β-CIT SPECT scans, a rhesus monkey was treated with MDMA (5 mg/kg, s.c. twice daily for 4 consecutive days). SPECT studies 4, 10, and 31 days after MDMA treatment revealed decreases in [123I]β-CIT binding ratios in the SERT-rich brain region studied (hypothalamic/midbrain region), with SERT density reduced by 39% in this brain region 31 days after treatment. Data obtained with SPECT studies correlated well with SERT density determined with autoradiography after sacrifice of the animal (-34%). In addition, ex vivo [123I]β-CIT binding studies in rats 1 week after treatment with neurotoxic doses of MDMA (20 mg/kg s.c. twice daily for 4 consecutive days) revealed significant reductions in [123I]β-CIT binding in SERT-rich regions (including the hypothalamus) when compared to saline-treated rats. The combined results of these studies indicate that SPECT imaging of SERT with [123I]β-CIT can detect changes in SERT density secondary to MDMA-induced neurotoxicity in the hypothalamic/midbrain region, and possibly other brain regions.

KW - 5-HT

KW - [I]β-CIT SPECT

KW - MDMA

KW - Neurotoxicity

KW - Validity

UR - http://www.scopus.com/inward/record.url?scp=0036887676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036887676&partnerID=8YFLogxK

U2 - 10.1002/syn.10130

DO - 10.1002/syn.10130

M3 - Article

C2 - 12325046

AN - SCOPUS:0036887676

VL - 46

SP - 199

EP - 205

JO - Synapse

JF - Synapse

SN - 0887-4476

IS - 3

ER -